No black box warning on record for Clomiphene Citrate

As of the latest FDA labeling reviewed, Clomiphene Citrate (CLOMIPHENE CITRTAE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clomiphene Citrate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Visual Symptoms Patients should be advised that blurring or other visual symptoms such as spots or flashes (scintillating scotomata) may occasionally occur during therapy with clomiphene citrate. These visual symptoms increase in incidence with increasing total dose or therapy duration. These visual disturbances are usually reversible; however, cases of prolonged visual disturbance have b

No black box warning on record for Clomiphene Citrate

Other warnings & precautions

WARNINGS Visual Symptoms Patients should be advised that blurring or other visual symptoms such as spots or flashes (scintillating scotomata) may occasionally occur during therapy with clomiphene citrate. These visual symptoms increase in incidence with increasing total dose or therapy duration. These visual disturbances are usually reversible; however, cases of prolonged visual disturbance have b

Clomiphene Citrate Black Box Warning

No black box warning on record for Clomiphene Citrate

Other warnings & precautions

Clomiphene Citrate Black Box Warning

No black box warning on record for Clomiphene Citrate

Other warnings & precautions